TAIEquity · Weekly research terminal

6949

Pell Bio-Med Technology Co., Ltd.

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
943.00 TWD
Fair value
304.63 TWD
Next-week expectancy
Undecided 53.96%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

6949

Pell Bio-Med Technology Co., Ltd.

Healthcare Biotechnology

Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products. It offers autologous adipose-derived stem cell (ADSC) products to treat osteoarthritis and cartilage defects in the knee; cytokine-induced Killer cells to treat various tumors; and dendritic cell-activated cytokine-induced killer to treat solid tumors. The company is also involved in the phase 1/2 multicenter …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
70,138,503,168
Fair value reference
304.63
Next-week expectancy
Undecided · 53.96%

Over the latest 12 completed weeks ending 2026-08-07, 6949 rose 40.96%, moving from 669.00 to 943.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 29.26 and has improved across the 12-week window. Market Dynamics is 0.70 on the latest week. Next-week expectancy is undecided at 53.96% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
943.00
12-Week Change
40.96%
Trend Signal
Active
Next-Week Expectancy
Undecided 53.96%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
943.00
12-Week Change
40.96%
Trend Signal
Active
Next-Week Expectancy
Undecided 53.96%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
29.26
Market Dynamics
0.70

Over the latest 12 completed weeks ending 2026-08-07, 6949 rose 40.96%, moving from 669.00 to 943.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 29.26 and has improved across the 12-week window. Market Dynamics is 0.70 on the latest week. Next-week expectancy is undecided at 53.96% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
1762 Chunghwa Chemical Synthesis & Biotech Co., Ltd. TAI 7 Aug 2026 32.20 35.75 31.60 35.75 11.02%
6589 EirGenix Inc. TAI 7 Aug 2026 44.60 48.90 44.30 48.20 8.07%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6919 CALIWAY BIOPHARMACEUTICALS CO L TAI 7 Aug 2026 102.00 111.00 102.00 105.00 2.94%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
1733 Apex Biotechnology Corp. TAI 7 Aug 2026 31.30 33.10 30.80 32.00 2.24%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
3164 GenMont Biotech Incorporation TAI 7 Aug 2026 16.25 16.60 16.00 16.40 0.92%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context